EHC
Encompass Health Corporation
NYSEUSDEQUITY
Healthcare
DELAYED
Buy
+45/100
Last price
124.69
▲ 3.72 (3.08%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
121.93
Prev close
120.97
Day high
124.91
Day low
120.98
Volume
1.30M
Market cap
$12.30B
P/E (TTM)
20.24
52W range
92.77 – 127.99
Day trading desk
Gap from prior close
+0.79%
Prior close 120.97
VWAP
124.49
+0.16% from price
Relative volume
3.03×
Unusually busy
Session range
3.24%
120.98 – 124.91
Position in range
95%
Near session high
ATR (14D)
3.09
2.48% of price
Prior day high
122.66
PDH
Prior day low
118.97
PDL
Bid / ask spread
—
Quote not published
Session volume
2.79M
Avg 919.46K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+0.91%
-1.0%
1M
+2.38%
+1.2%
3M
+13.10%
+8.6%
6M
+18.00%
-0.2%
YTD
+17.48%
+3.2%
1Y
+1.18%
-15.2%
3Y
+85.66%
+3.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on EHC open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-190.32K
Net selling
Buy transactions
29
49.05K shares
Sell transactions
7
239.37K shares
Net transactions
+36
Buys less sells
Sell : buy shares
4.9 : 1
Mixed
Insider-held shares
855.32K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 31, 26 | PRICE ANDREW L. Officer |
SELL | 5.21K | $630.17K | Direct |
| Aug 31, 26 | DARBY JOHN PATRICK General Counsel |
SELL | 4.86K | $588.25K | Direct |
| Aug 31, 26 | DARBY JOHN PATRICK General Counsel |
CONVERSION | 4.86K | $170.32K | Direct |
| Aug 10, 26 | TARR MARK J Chief Executive Officer |
SELL | 173.15K | $21.72M | Direct |
| Aug 10, 26 | COLTHARP DOUGLAS EDWARD Chief Financial Officer |
SELL | 18.87K | $2.37M | Direct |
| Aug 10, 26 | DARBY JOHN PATRICK General Counsel |
SELL | 8.91K | $1.12M | Direct |
| Jul 16, 26 | REIDY CHRISTOPHER R Director |
STOCK | 340 | $35.86K | Direct |
| Jul 16, 26 | CHRISTIE EDWARD M III Director |
STOCK | 259 | $27.88K | Direct |
| Jul 15, 26 | HERMAN JOAN E Director |
STOCK | 85 | $0 | Direct |
| Jul 15, 26 | CARMICHAEL GREGORY D Director |
STOCK | 29 | $0 | Direct |
| Jul 15, 26 | KATZ LESLYE G Director |
STOCK | 85 | $0 | Direct |
| Jul 15, 26 | WILLIAMS TERRANCE Director |
STOCK | 29 | $0 | Direct |
| Jul 15, 26 | O'CONNOR KEVIN J Director |
STOCK | 19 | $0 | Direct |
| Jul 15, 26 | HAYES CAIN A. Director |
STOCK | 4 | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CHARBONNEAU ELISSA JOY |
Officer | 22.76K | Stock Award(Grant) |
COLTHARP DOUGLAS EDWARD |
Chief Financial Officer | 241.37K | Sale |
DARBY JOHN PATRICK |
General Counsel | 75.04K | Sale |
FAY EDMUND M |
Officer and Treasurer | 86.33K | Stock Gift |
HERMAN JOAN E |
Director | 49.64K | Stock Award(Grant) |
KATZ LESLYE G |
Director | 49.64K | Stock Award(Grant) |
PRICE ANDREW L. |
Officer | 69.48K | Sale |
SCHLICHTING NANCY M |
Director | 22.97K | Stock Award(Grant) |
TARR MARK J |
Chief Executive Officer | 267.81K | Sale |
TUER PATRICK WILLIAM |
Chief Operating Officer | 24.75K | Sale |
Fundamentals
Market cap$12.30B
Enterprise value$15.90B
Revenue (TTM)$6.21B
Gross profit$2.72B
EBITDA$1.46B
Net income$603.70M
EPS (TTM)$6.16
Free cash flow$229.92M
Total cash$107.70M
Total debt$2.84B
Book value / share$26.29
Shares outstanding98.65M
Float97.65M
Short % of float3.43%
Dividend yield0.67%
Beta (5Y)0.60
Valuation & profitability ratios
Trailing P/E20.24
Forward P/E18.67
PEG ratio0.41
Price / sales—
Price / book4.74
EV / revenue2.56
EV / EBITDA10.86
Gross margin43.86%
Operating margin18.05%
Profit margin10.01%
Return on equity24.97%
Return on assets9.80%
Debt / equity82.12
Current ratio1.19
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $5.94B | $5.37B | $4.80B | $4.35B | +10.5% |
| Operating revenue | $5.94B | $5.37B | $4.80B | $4.35B | +10.5% |
| Cost of revenue | $254.40M | $3.14B | $2.82B | $2.60B | -91.9% |
| Gross profit | $5.68B | $2.23B | $1.98B | $1.75B | +154.4% |
| Selling, general & admin | $3.41B | $266.50M | $258.00M | $209.00M | +1,180.0% |
| Total operating expense | $4.63B | $1.37B | $1.25B | $1.12B | +238.1% |
| Operating income | $1.05B | $864.50M | $731.80M | $630.20M | +21.8% |
| Net interest income | -$123.20M | -$137.40M | -$143.50M | -$175.70M | +10.3% |
| Pre-tax income | $953.00M | $749.60M | $607.20M | $450.80M | +27.1% |
| Tax provision | $192.90M | $150.20M | $132.20M | $100.10M | +28.4% |
| Net income | $566.20M | $455.70M | $352.00M | $271.00M | +24.2% |
| Net income to common | $564.70M | $452.90M | $349.60M | $269.80M | +24.7% |
| Basic EPS | 5.62 | 4.53 | 3.51 | 2.72 | +24.1% |
| Diluted EPS | 5.54 | 4.46 | 3.47 | 2.70 | +24.2% |
| EBIT | $1.08B | $887.00M | $750.70M | $626.50M | +21.3% |
| EBITDA | $1.40B | $1.19B | $1.02B | $870.10M | +18.3% |
| Basic shares | 100.50M | 99.90M | 99.50M | 99.20M | +0.6% |
| Diluted shares | 102.20M | 102.20M | 101.30M | 100.40M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $72.20M | $85.40M | $69.10M | $21.80M | -15.5% |
| Cash & short-term investments | $72.20M | $85.40M | $69.10M | $21.80M | -15.5% |
| Accounts receivable | $619.20M | $598.80M | $611.60M | $536.80M | +3.4% |
| Total current assets | $905.90M | $886.90M | $841.80M | $717.20M | +2.1% |
| Property, plant & equipment | $4.31B | $3.85B | $3.51B | $3.15B | +12.2% |
| Goodwill & intangibles | $1.63B | $1.58B | $1.56B | $1.55B | +2.7% |
| Total assets | $7.09B | $6.53B | $6.10B | $5.64B | +8.5% |
| Total current liabilities | $836.40M | $841.00M | $656.40M | $575.90M | -0.5% |
| Current debt | $43.60M | $138.60M | $24.80M | $25.20M | -68.5% |
| Long-term debt | $2.45B | $2.36B | $2.69B | $2.74B | +3.7% |
| Total debt | $2.71B | $2.71B | $2.93B | $2.99B | +0.0% |
| Total liabilities | $3.81B | $3.69B | $3.81B | $3.77B | +3.5% |
| Retained earnings | $1.29B | $796.70M | $406.50M | $115.70M | +61.8% |
| Shareholder equity | $2.44B | $2.07B | $1.65B | $1.31B | +18.0% |
| Working capital | $69.50M | $45.90M | $185.40M | $141.30M | +51.4% |
| Net tangible assets | $812.30M | $484.20M | $88.00M | -$235.20M | +67.8% |
| Shares issued | 116.04M | 116.04M | 115.42M | 114.78M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $760.10M | $599.40M | $475.00M | $350.70M | +26.8% |
| Depreciation & amortisation | $327.90M | $299.60M | $273.90M | $243.60M | +9.4% |
| Stock-based compensation | $56.50M | $48.30M | $50.60M | $29.20M | +17.0% |
| Change in working capital | $4.30M | $21.90M | $50.30M | -$30.40M | -80.4% |
| Operating cash flow | $1.18B | $1.00B | $850.80M | $705.80M | +17.2% |
| Capital expenditure | -$736.40M | -$642.50M | -$583.10M | -$584.10M | -14.6% |
| Investing cash flow | -$764.60M | -$653.30M | -$602.80M | -$627.00M | -17.0% |
| Share buybacks | -$158.00M | -$31.10M | $0 | $0 | -408.0% |
| Dividends paid | -$71.10M | -$62.80M | -$60.40M | -$99.00M | -13.2% |
| Financing cash flow | -$431.20M | -$330.60M | -$197.20M | -$145.70M | -30.4% |
| Free cash flow | $439.20M | $360.30M | $267.70M | $121.70M | +21.9% |
| End cash position | $102.90M | $123.10M | $104.20M | $53.40M | -16.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.60B | $1.59B | $1.54B | $1.48B | $1.46B | +0.7% |
| Operating revenue | $1.60B | $1.54B | $1.67B | $1.43B | $1.46B | +4.0% |
| Cost of revenue | $66.10M | $64.30M | $64.50M | $64.60M | $830.80M | +2.8% |
| Gross profit | $1.53B | $1.52B | $1.48B | $1.41B | $626.90M | +0.6% |
| Selling, general & admin | $897.60M | $891.50M | $884.00M | $855.80M | $74.10M | +0.7% |
| Total operating expense | $1.24B | $1.22B | $1.20B | $1.17B | $367.80M | +1.8% |
| Operating income | $288.40M | $301.60M | $283.40M | $243.60M | $259.10M | -4.4% |
| Net interest income | -$32.80M | -$31.80M | -$30.20M | -$30.80M | -$30.40M | -3.1% |
| Pre-tax income | $261.60M | $288.70M | $257.70M | $219.90M | $236.80M | -9.4% |
| Tax provision | $53.60M | $56.40M | $55.40M | $44.90M | $51.00M | -5.0% |
| Net income | $153.90M | $194.50M | $146.10M | $126.50M | $142.10M | -20.9% |
| Net income to common | $153.90M | $194.50M | $144.60M | $126.50M | $142.10M | -20.9% |
| Basic EPS | 1.55 | 1.96 | 1.45 | 1.26 | 1.41 | -20.9% |
| Diluted EPS | 1.54 | 1.93 | 1.43 | 1.24 | 1.39 | -20.2% |
| EBIT | $294.40M | $320.50M | $287.90M | $250.70M | $267.20M | -8.1% |
| EBITDA | $384.80M | $407.80M | $374.30M | $333.10M | $347.10M | -5.6% |
| Basic shares | 98.80M | 99.20M | 100.20M | 100.50M | 100.60M | -0.4% |
| Diluted shares | 100.00M | 100.60M | 102.00M | 102.30M | 102.30M | -0.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $107.70M | $110.50M | $72.20M | $48.70M | $99.10M | -2.5% |
| Cash & short-term investments | $107.70M | $110.50M | $72.20M | $48.70M | $99.10M | -2.5% |
| Accounts receivable | $687.30M | $676.00M | $619.20M | $610.80M | $612.50M | +1.7% |
| Total current assets | $1.04B | $1.03B | $905.90M | $869.80M | $918.10M | +1.2% |
| Property, plant & equipment | $4.54B | $4.42B | $4.31B | $4.14B | $4.04B | +2.7% |
| Goodwill & intangibles | $1.63B | $1.62B | $1.63B | $1.59B | $1.60B | +0.8% |
| Total assets | $7.46B | $7.31B | $7.09B | $6.87B | $6.79B | +2.0% |
| Total current liabilities | $873.40M | $876.80M | $836.40M | $762.00M | $865.10M | -0.4% |
| Current debt | $35.90M | $42.90M | $43.60M | $39.00M | $139.20M | -16.3% |
| Long-term debt | $2.60B | $2.53B | $2.45B | $2.39B | $2.32B | +2.7% |
| Total debt | $2.84B | $2.79B | $2.71B | $2.66B | $2.69B | +1.9% |
| Total liabilities | $4.00B | $3.95B | $3.81B | $3.68B | $3.70B | +1.3% |
| Retained earnings | $1.60B | $1.46B | $1.29B | $1.16B | $1.06B | +9.2% |
| Shareholder equity | $2.60B | $2.52B | $2.44B | $2.37B | $2.28B | +3.0% |
| Working capital | $167.60M | $152.30M | $69.50M | $107.80M | $53.00M | +10.0% |
| Net tangible assets | $967.40M | $903.80M | $812.30M | $778.90M | $681.20M | +7.0% |
| Shares issued | 98.80M | 116.16M | 116.04M | 116.77M | 116.73M | -14.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $208.00M | $232.30M | $202.30M | $175.00M | $185.80M | -10.5% |
| Depreciation & amortisation | $90.40M | $87.30M | $86.40M | $82.40M | $79.90M | +3.6% |
| Stock-based compensation | $13.80M | $11.50M | $18.40M | $14.30M | $14.30M | +20.0% |
| Change in working capital | -$27.10M | -$33.80M | $13.90M | $1.80M | -$3.90M | +19.8% |
| Operating cash flow | $282.60M | $313.10M | $346.00M | $270.80M | $270.20M | -9.7% |
| Capital expenditure | -$220.30M | -$162.40M | -$229.30M | -$187.10M | -$156.90M | -35.7% |
| Investing cash flow | -$235.60M | -$150.10M | -$239.40M | -$201.30M | -$165.40M | -57.0% |
| Share buybacks | -$74.20M | -$71.60M | -$76.30M | -$24.90M | -$24.70M | -3.6% |
| Dividends paid | -$18.90M | -$20.30M | -$19.00M | -$17.00M | -$17.10M | +6.9% |
| Financing cash flow | -$76.90M | -$102.50M | -$97.40M | -$113.20M | -$90.20M | +25.0% |
| Free cash flow | $62.30M | $150.70M | $116.70M | $83.70M | $113.30M | -58.7% |
| End cash position | $133.50M | $163.40M | $102.90M | $93.70M | $137.40M | -18.3% |
Options analytics
Put / call volume
0.29
Call-heavy session
Put / call open interest
17.27
Positioning, not flow
Max pain
100.00
-19.8% from spot
ATM implied vol
0.4%
Nearest strike to spot
Skew (10% OTM)
+70.0%
Puts bid over calls
Call volume
574
Contracts, this expiry
Put volume
167
Contracts, this expiry
Heaviest call OI
100.00
7 contracts
Heaviest put OI
85.00
117 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 1.48 | 1.55 | +4.8% |
| Mar 2026 | 1.49 | 1.60 | +7.1% |
| Dec 2025 | 1.30 | 1.46 | +12.1% |
| Sep 2025 | 1.19 | 1.23 | +3.2% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.36 | 12 | $1.60B | +8.4% |
| Next quarter | 1.60 | 12 | $1.67B | +8.4% |
| Current year | 6.11 | 13 | $6.46B | +8.8% |
| Next year | 6.68 | 13 | $6.99B | +8.3% |
Analyst targets & ownership
Mean target$148.17
High target$155.00
Low target$140.00
Implied upside18.83%
Analyst count12
ConsensusSTRONG BUY
Strong buy / Buy1 / 12
Hold0
Sell / Strong sell0 / 0
Held by insiders0.87%
Held by institutions100.91%
Institutions holding807
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
122.13
+2.10% from price
SMA 20
122.16
+2.07% from price
SMA 50
120.79
+3.23% from price
SMA 100
113.07
+10.28% from price
SMA 200
108.32
+15.11% from price
EMA 12
122.03
+2.18% from price
EMA 26
121.59
+2.55% from price
EMA 50
119.54
+4.31% from price
RSI (14)
59.5
Neutral
MACD (12,26,9)
0.44
Hist -0.18
ATR (14)
3.09
2.48% of price
Realised vol 30D
17.1%
Annualised
Bollinger upper
124.90
20, 2σ
Bollinger lower
119.42
20, 2σ
50 / 200 cross
Golden
120.79 vs 108.32
Trend bias
Above 200
+15.11%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.08
Less volatile than market
Correlation to SPY
0.04
Largely independent
Realised vol 30D
17.1%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-26.2%
Peak to trough
Max drawdown 5Y
-27.3%
Peak to trough
ATR 14
3.09
2.48% of price
Beta (reported)
0.60
5Y monthly, from filing
Short interest
Shares short
3.00M
Prior 3.27M
Change vs prior
-8.4%
Shorts covering
% of float
3.43%
Normal
% of shares out
3.04%
Against total outstanding
Days to cover
3.7
Liquid
Float
97.65M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 10, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Aug 7, 26 | UBS | MAINTAINED | Buy | Buy |
| Aug 7, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Aug 6, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| May 28, 26 | TD Cowen | INITIATED | — | Buy |
| May 5, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Feb 6, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Oct 30, 25 | Barclays | MAINTAINED | Overweight | Overweight |
| Oct 2, 25 | UBS | MAINTAINED | Buy | Buy |
| Sep 16, 25 | Keybanc | MAINTAINED | Overweight | Overweight |
| Sep 10, 25 | B of A Securities | MAINTAINED | Buy | Buy |
| Aug 14, 25 | Truist Securities | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate$0.84 / yr
Forward yield0.67%
5-year avg yield0.86%
Payout ratio12.71%
Ex-dividend dateOct 1, 2026
Next pay dateOct 15, 2026
Last split1257:1000
Split dateJul 1, 2022
SEC filings
Offering Registrations
S-3ASR · 2026-08-19
Corporate Changes & Voting Matters
8-K · 2026-08-13
Periodic Financial Reports
10-Q · 2026-08-07
Corporate Changes & Voting Matters
8-K · 2026-08-05
Corporate Changes & Voting Matters
8-K · 2026-06-01
Corporate Changes & Voting Matters
8-K · 2026-05-15
Corporate Changes & Voting Matters
8-K · 2026-05-11
Periodic Financial Reports
10-Q · 2026-05-01
Headlines
Encompass Health Opens Rehabilitation Hospital in Bangor, Maine
MT Newswires · 7h ago
Encompass Health Rehabilitation Hospital of Bangor now open in Maine
PR Newswire · 8h ago
1 Momentum Stock to Research Further and 2 We Turn Down
StockStory · 5d ago
Encompass Health announces date of 2026 third-quarter earnings call
PR Newswire · 5d ago
Will Encompass Health’s Small-Format Expansion Strategy Reshape EHC’s Capacity-Led Growth Narrative?
Simply Wall St. · 9d ago
Encompass Health (EHC) Could Be 20% Undervalued As Rehab Expansion Builds Out
Simply Wall St. · 9d ago
Encompass Health Adds New Capacity With First Small-Format Hospital
Zacks · 12d ago
2 Cash-Producing Stocks with Promising Prospects and 1 Facing Headwinds
StockStory · 12d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.